Key Takeaways
- • Hedge funds have rotated significantly into healthcare, which now represents 18.7% of total net exposure as of June 2026, surpassing information technology as the largest sector holding among 991 hedge funds tracked by Goldman Sachs.
- • The Goldman Sachs analysis covers hedge funds with $5.4 trillion in gross equity exposure, providing a comprehensive view of institutional allocation shifts across the alternative investment community.
- • This sector rotation signals a major strategic reallocation of capital away from technology and toward healthcare, reflecting changing risk assessments and investment thesis priorities among sophisticated institutional managers.
Summary
Hedge funds have executed a substantial capital rotation into the healthcare sector, marking a significant shift in institutional investment priorities through mid-2026. According to Goldman Sachs data spanning 991 hedge funds with $5.4 trillion in gross equity exposure, healthcare has become the largest sector position within hedge fund portfolios, accounting for 18.7% of total net exposure as of June 2026.
This reallocation displaced information technology from its previous position as the leading sector holding, reflecting a meaningful strategic recalibration among alternative investment managers. The scale of the shift underscores the breadth of conviction among the hedge fund community regarding healthcare sector valuations, fundamentals, or defensive characteristics relative to technology equities.
The Goldman Sachs analysis provides quantitative validation of qualitative market observations regarding sector rotation trends. With nearly $5.4 trillion in gross equity exposure tracked across the surveyed funds, the 18.7% healthcare weighting represents a substantial pool of capital deployed into the sector, likely spanning pharmaceutical companies, medical device manufacturers, healthcare services providers, and biotech firms.
This shift has material implications for healthcare sector valuations, equity research priorities, and relative performance dynamics between healthcare and technology stocks. The concentration of hedge fund capital in healthcare may reflect changing macroeconomic conditions, valuation adjustments, dividend yield considerations, or evolving thesis around regulatory and legislative environments affecting each sector differently.
This reallocation displaced information technology from its previous position as the leading sector holding, reflecting a meaningful strategic recalibration among alternative investment managers. The scale of the shift underscores the breadth of conviction among the hedge fund community regarding healthcare sector valuations, fundamentals, or defensive characteristics relative to technology equities.
The Goldman Sachs analysis provides quantitative validation of qualitative market observations regarding sector rotation trends. With nearly $5.4 trillion in gross equity exposure tracked across the surveyed funds, the 18.7% healthcare weighting represents a substantial pool of capital deployed into the sector, likely spanning pharmaceutical companies, medical device manufacturers, healthcare services providers, and biotech firms.
This shift has material implications for healthcare sector valuations, equity research priorities, and relative performance dynamics between healthcare and technology stocks. The concentration of hedge fund capital in healthcare may reflect changing macroeconomic conditions, valuation adjustments, dividend yield considerations, or evolving thesis around regulatory and legislative environments affecting each sector differently.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.